Search
for
Sort by
Research 391–420 of 1000+
- Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial
- Intramuscular Compound Betamethasone for the Treatment of Telogen Effluvium: A Single‐Center Real‐World Study
- Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single‐Center Experience
- Global Epidemiology of Telogen Effluvium after COVID-19 Pandemic: A Systematic Review and Modeling Study
- Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation
- Telogen Effluvium: A Review
- Management of telogen effluvium during the COVID‐19 emergency: Psychological implications
- Pregnancy, hair loss, and the pill.
- Effects of anticonvulsant drugs on chromosomes.
- Stem cell apoptosis in HIV‐1 alopecia
- Presence of mast cells and mast cell degranulation in scalp biopsies of telogen effluvium
- Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium
- Comparative evaluation of two Unani formulation combinations in the treatment of Telogen Effluvium: A randomized, single-blind clinical trial
- Recovery Effects of Oral Supplementation with Polar Lipid-Rich Wheat Extracts on Acute Telogen Effluvium: A Randomized Double-Blind Placebo-Controlled Study
- Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium
- Telogen Effluvium and Trichodynia in Different Severity Groups of Post COVID-19 Patients
- An analytical study of serum ferritin, vitamin D, and thyroid function in females with diffuse hair loss
- A preliminary result of adipose derived stem cell treatment for female pattern hair loss
- The Assessment and Treatment of Geezers
- Shedding: How to manage a common cause of hair loss
- DRUG‐ASSOCIATED ALOPECIA
- Expert consensus on the management of telogen effluvium in India
- Acne and Hidden Iodides
- Diffuse scalp hair loss due to levothyroxine overdose
- Efficacy of QR678 Neo<sup>®</sup> hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- A case control study of relationship between body iron stores and non scarring diffuse hair loss in non menopausal women
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- Hair in health and disease: an introduction